Precision Management of Late Endocrine Effects in Cancer Survivors

Learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments, including hypothalamic pituitary dysfunction, thyroid disorders, obesity and diabetes mellitus.

Wassim Chemaitilly, MD Laurie E. Cohen, MD Danielle N. Friedman, MD, MS Steven G. Waguespack, MD Released: March 18, 2021

When and how do I retest for GH deficiency and how soon do I start GH replacement in cancer survivors? Read my answers to these questions and more.

Laurie E. Cohen, MD Released: April 22, 2021

When and how do I manage hypothyroidism after immune checkpoint inhibitors, MIBG treatment, or mitotane, and what is the mechanism of hyperthyroidism in cancer survivors? Read my answers to these questions and more.

Steven G. Waguespack, MD Released: April 26, 2021

Read how adipose dysfunction and insulinopenia after irradiation are just some of the areas being explored.

Danielle N. Friedman, MD, MS Released: April 22, 2021

From ENDO 2021, learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments, including hypothalamic pituitary dysfunction, thyroid disorders, obesity and diabetes mellitus.

Wassim Chemaitilly, MD Laurie E. Cohen, MD Danielle N. Friedman, MD, MS Steven G. Waguespack, MD ABIM MOC: maximum of 1.5 Medical Knowledge MOC point(s) Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: March 22, 2021 Expired: No longer available for credit